Beyond death and graft survival—Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase

Justin R. Parekh, Stuart M. Greenstein, Debra L. Sudan, Arielle Grieco, Mark E. Cohen, Bruce L. Hall, Clifford Y. Ko, Ryutaro Hirose

Research output: Contribution to journalArticle

Abstract

The National Surgical Quality Program (NSQIP) Transplant program was designed by transplant surgeons from the ground up to track posttransplant outcomes beyond basic recipient and graft survival. After an initial pilot phase, the program has expanded to 29 participating sites and enrolled more than 4300 recipient-donor pairs into the database, including 1444 completed liver transplant cases. In this analysis, surgical site infection (SSI), urinary tract infection (UTI), and unplanned reoperation/intervention after liver transplantation were evaluated. We observed impressive variation in the crude incidence between sites for SSI (0%-29%), UTI (0%-10%), and reoperation/intervention (0%-57%). After adjustment for donor and recipient factors, at least 1 site was identified as an outlier for each of the analyzed outcomes. For the first time, the field of transplantation has data that demonstrate variation in liver recipient outcomes beyond death and graft survival between sites. More importantly, NSQIP Transplant provides a powerful platform to improve care beyond basic patient and graft survival.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
DOIs
StatePublished - Jan 1 2019

Fingerprint

Graft Survival
Transplants
Surgical Wound Infection
Liver
Reoperation
Urinary Tract Infections
Tissue Donors
Liver Transplantation
Transplantation
Databases
Incidence

Keywords

  • clinical research/practice
  • health services and outcomes research
  • liver allograft function/dysfunction
  • liver transplantation/hepatology
  • quality of care/care delivery

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Beyond death and graft survival—Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. / Parekh, Justin R.; Greenstein, Stuart M.; Sudan, Debra L.; Grieco, Arielle; Cohen, Mark E.; Hall, Bruce L.; Ko, Clifford Y.; Hirose, Ryutaro.

In: American Journal of Transplantation, 01.01.2019.

Research output: Contribution to journalArticle

Parekh, Justin R. ; Greenstein, Stuart M. ; Sudan, Debra L. ; Grieco, Arielle ; Cohen, Mark E. ; Hall, Bruce L. ; Ko, Clifford Y. ; Hirose, Ryutaro. / Beyond death and graft survival—Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. In: American Journal of Transplantation. 2019.
@article{10ec6074b81e47268f2f858f70261af9,
title = "Beyond death and graft survival—Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase",
abstract = "The National Surgical Quality Program (NSQIP) Transplant program was designed by transplant surgeons from the ground up to track posttransplant outcomes beyond basic recipient and graft survival. After an initial pilot phase, the program has expanded to 29 participating sites and enrolled more than 4300 recipient-donor pairs into the database, including 1444 completed liver transplant cases. In this analysis, surgical site infection (SSI), urinary tract infection (UTI), and unplanned reoperation/intervention after liver transplantation were evaluated. We observed impressive variation in the crude incidence between sites for SSI (0{\%}-29{\%}), UTI (0{\%}-10{\%}), and reoperation/intervention (0{\%}-57{\%}). After adjustment for donor and recipient factors, at least 1 site was identified as an outlier for each of the analyzed outcomes. For the first time, the field of transplantation has data that demonstrate variation in liver recipient outcomes beyond death and graft survival between sites. More importantly, NSQIP Transplant provides a powerful platform to improve care beyond basic patient and graft survival.",
keywords = "clinical research/practice, health services and outcomes research, liver allograft function/dysfunction, liver transplantation/hepatology, quality of care/care delivery",
author = "Parekh, {Justin R.} and Greenstein, {Stuart M.} and Sudan, {Debra L.} and Arielle Grieco and Cohen, {Mark E.} and Hall, {Bruce L.} and Ko, {Clifford Y.} and Ryutaro Hirose",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/ajt.15357",
language = "English (US)",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Beyond death and graft survival—Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase

AU - Parekh, Justin R.

AU - Greenstein, Stuart M.

AU - Sudan, Debra L.

AU - Grieco, Arielle

AU - Cohen, Mark E.

AU - Hall, Bruce L.

AU - Ko, Clifford Y.

AU - Hirose, Ryutaro

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The National Surgical Quality Program (NSQIP) Transplant program was designed by transplant surgeons from the ground up to track posttransplant outcomes beyond basic recipient and graft survival. After an initial pilot phase, the program has expanded to 29 participating sites and enrolled more than 4300 recipient-donor pairs into the database, including 1444 completed liver transplant cases. In this analysis, surgical site infection (SSI), urinary tract infection (UTI), and unplanned reoperation/intervention after liver transplantation were evaluated. We observed impressive variation in the crude incidence between sites for SSI (0%-29%), UTI (0%-10%), and reoperation/intervention (0%-57%). After adjustment for donor and recipient factors, at least 1 site was identified as an outlier for each of the analyzed outcomes. For the first time, the field of transplantation has data that demonstrate variation in liver recipient outcomes beyond death and graft survival between sites. More importantly, NSQIP Transplant provides a powerful platform to improve care beyond basic patient and graft survival.

AB - The National Surgical Quality Program (NSQIP) Transplant program was designed by transplant surgeons from the ground up to track posttransplant outcomes beyond basic recipient and graft survival. After an initial pilot phase, the program has expanded to 29 participating sites and enrolled more than 4300 recipient-donor pairs into the database, including 1444 completed liver transplant cases. In this analysis, surgical site infection (SSI), urinary tract infection (UTI), and unplanned reoperation/intervention after liver transplantation were evaluated. We observed impressive variation in the crude incidence between sites for SSI (0%-29%), UTI (0%-10%), and reoperation/intervention (0%-57%). After adjustment for donor and recipient factors, at least 1 site was identified as an outlier for each of the analyzed outcomes. For the first time, the field of transplantation has data that demonstrate variation in liver recipient outcomes beyond death and graft survival between sites. More importantly, NSQIP Transplant provides a powerful platform to improve care beyond basic patient and graft survival.

KW - clinical research/practice

KW - health services and outcomes research

KW - liver allograft function/dysfunction

KW - liver transplantation/hepatology

KW - quality of care/care delivery

UR - http://www.scopus.com/inward/record.url?scp=85064505835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064505835&partnerID=8YFLogxK

U2 - 10.1111/ajt.15357

DO - 10.1111/ajt.15357

M3 - Article

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

ER -